Maternal Nutrition – Quarterly Progress Report (Cumulative)

Year   
Normalized   

Quarterly Progress Report (QPR) on age-group wise service deliveries and information on distribution of Iron and Folic Acid (IFA) syrup and tablets- Pink, Blue & Red, Albendazole tablets among the 6 focused age groups. The information is derived on the basis of data updates available from HMIS indicators (Numerator) calculated using the eligible age specific respective denominators for each age group. *The GOI quarter reporting year starts from April and ends in March of the subsequent year (Q1-April to June, Q2-July to September, Q3- October to December and Q4 January to March (of subsequent year)).

Maternal Nutrition in Percentage

India

Maternal Nutrion KPI

ANC Services


Year Upto       Q1 Upto       Q2 Upto       Q3 Upto       Q4
2021-2290.20.00.00.0
2021-2276.90.00.00.0
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2020-2186.590.592.992.6
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2019-2087.589.390.390.8
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2018-1980.382.183.784.8
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2017-1870.773.576.177.3
2021-2250.70.00.00.0
2021-2243.30.00.00.0
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2020-2147.148.349.149.0
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2019-2040.642.143.043.7
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2018-1935.236.037.137.5
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2017-1824.826.928.329.3
2021-2285.30.00.00.0
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2020-2187.289.189.792.5
2020-2187.289.189.792.5
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2019-2095.095.095.095.0
2019-2095.095.095.095.0
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2018-1995.095.095.095.0
2018-1995.095.095.095.0
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2017-1895.095.095.095.0
2017-1895.095.095.095.0
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2020-2168.574.778.578.2
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2019-2071.075.477.977.8
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2018-1966.169.472.672.7
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2017-1854.358.861.762.4
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2020-2175.479.081.982.6
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2019-2062.766.669.270.6
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2018-1950.452.354.956.9
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2017-1833.836.339.141.0
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2020-2139.738.237.335.7
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2019-2038.638.337.536.2
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2018-1933.533.232.431.6
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2017-1833.832.631.530.9
IFA Supplement


Year Upto       Q1 Upto       Q2 Upto       Q3 Upto       Q4
2021-2262.80.00.00.0
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2020-2161.663.364.664.8
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2019-2068.770.871.471.1
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2018-1970.970.671.470.8
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2017-1862.965.466.766.4
2021-223.00.00.00.0
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2020-213.03.13.23.2
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2019-203.53.73.73.7
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2018-193.43.63.73.7
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2017-183.23.53.63.6
2021-221.70.00.00.0
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2020-211.81.91.91.9
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2019-202.22.32.32.2
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2018-191.81.92.02.0
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2017-181.41.61.71.6
HMIS 1.4.2 + HMIS 1.4.32020-2132.333.233.934.0
HMIS 1.4.2 + HMIS 1.4.32019-2036.137.237.637.4
HMIS 1.4.2 + HMIS 1.4.32018-1937.237.137.637.2
HMIS 1.4.2 + HMIS 1.4.32017-1833.034.435.235.0
2021-220.00.00.00.0
2021-2279.50.00.00.0
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2020-2167.867.868.769.4
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2019-2058.458.759.761.8
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2018-1949.749.549.951.0
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2017-1840.041.543.545.2
HRP


Year Upto       Q1 Upto       Q2 Upto       Q3 Upto       Q4
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2020-211.31.31.41.4
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2019-201.31.41.41.5
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2018-191.21.21.31.3
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2017-181.01.11.11.2
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2020-210.10.10.10.1
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2019-200.10.10.10.1
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2018-190.10.10.10.1
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2017-180.10.10.10.1
HMIS 1.3.1:
New cases of PW with hypertension detected
2020-211.81.92.02.0
HMIS 1.3.1:
New cases of PW with hypertension detected
2019-201.91.92.02.0
HMIS 1.3.1:
New cases of PW with hypertension detected
2018-191.91.92.01.9
HMIS 1.3.1:
New cases of PW with hypertension detected
2017-182.02.12.12.1
HMIS 1.5.2:
Number of PW tested positive for GDM
2020-210.40.40.40.5
HMIS 1.5.2:
Number of PW tested positive for GDM
2019-200.50.50.50.5
HMIS 1.5.2:
Number of PW tested positive for GDM
2018-190.50.50.50.5
HMIS 1.5.2:
Number of PW tested positive for GDM
2017-180.40.40.40.4
Stock


Year Upto       Q1 Upto       Q2 Upto       Q3 Upto       Q4
2021-2226.10.00.00.0
2021-2226.10.00.00.0
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2020-2122.924.527.028.5
2020-2122.924.527.028.5
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2019-2032.033.633.230.7
2019-2032.033.633.230.7
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2018-1928.326.827.727.1
2018-1928.326.827.727.1
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2017-1815.121.422.423.3
2017-1815.121.422.423.3
HMIS 19.15:
Number of stocks available for Albendazole tablets
2020-2148.763.375.677.7
HMIS 19.15:
Number of stocks available for Albendazole tablets
2019-2011.033.824.726.4
HMIS 19.15:
Number of stocks available for Albendazole tablets
2019-2095.095.084.174.7
HMIS 19.15:
Number of stocks available for Albendazole tablets
2018-1917.331.424.828.8
HMIS 19.15:
Number of stocks available for Albendazole tablets
2018-1981.981.077.678.5
HMIS 19.15:
Number of stocks available for Albendazole tablets
2017-186.021.017.525.4
HMIS 19.15:
Number of stocks available for Albendazole tablets
2017-1827.731.635.643.9
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2020-2124.926.022.321.1
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2019-2011.513.514.215.0
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2018-197.38.49.39.4
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2017-183.73.73.53.6